Free Trial
NASDAQ:THMO

ThermoGenesis (THMO) Stock Price, News & Analysis

ThermoGenesis logo

About ThermoGenesis Stock (NASDAQ:THMO)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
112 shs
Average Volume
3,353 shs
Market Capitalization
$2,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

Remove Ads
Receive THMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ThermoGenesis and its competitors with MarketBeat's FREE daily newsletter.

THMO Stock News Headlines

This almost killed Elon Musk (chilling details emerge)
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
North American Morning Briefing: Stock Futures, -2-
Why Is ThermoGenesis (THMO) Stock Down 37% Today?
See More Headlines

THMO Stock Analysis - Frequently Asked Questions

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) announced its quarterly earnings results on Friday, November, 12th. The company reported ($6.75) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.60) by $3.15. The firm had revenue of $3.16 million for the quarter, compared to analyst estimates of $3.06 million.

ThermoGenesis shares reverse split on Friday, December 23rd 2022. The 1-45 reverse split was announced on Friday, December 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of THMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ThermoGenesis investors own include FuelCell Energy (FCEL), Teladoc Health (TDOC), Zoom Video Communications (ZM), Bionano Genomics (BNGO), Co-Diagnostics (CODX), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/12/2021
Today
4/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Laboratory apparatus & furniture
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:THMO
Employees
40
Year Founded
1986

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.61 million
Price / Cash Flow
N/A
Book Value
($0.99) per share
Price / Book
N/A

Miscellaneous

Free Float
1,750,000
Market Cap
$2,000.00
Optionable
Not Optionable
Beta
2.47

Social Links

10 Stocks Set to Soar in Spring 2025 Cover

Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.

Get This Free Report

This page (NASDAQ:THMO) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners